Long-term therapy with chlorpropamide. 1959

A W ALVI, and J P MACLEAN

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D002747 Chlorpropamide A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277) Clorpropamid,Apo-Chlorpropamide,Diabinese,Glucamide,Insogen,Meldian
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A W ALVI, and J P MACLEAN
September 1965, JAMA,
A W ALVI, and J P MACLEAN
September 1967, Pennsylvania medicine,
A W ALVI, and J P MACLEAN
February 1964, Journal of the American Geriatrics Society,
A W ALVI, and J P MACLEAN
January 1966, IMJ. Illinois medical journal,
A W ALVI, and J P MACLEAN
September 1965, JAMA,
A W ALVI, and J P MACLEAN
June 1968, Naika. Internal medicine,
A W ALVI, and J P MACLEAN
June 1974, Diabetologia,
A W ALVI, and J P MACLEAN
April 1974, The Journal of clinical endocrinology and metabolism,
A W ALVI, and J P MACLEAN
April 1967, Journal of the Irish Medical Association,
A W ALVI, and J P MACLEAN
December 1974, Minerva pediatrica,
Copied contents to your clipboard!